Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from AOTI, Inc. ( (GB:AOTI) ) is now available.
AOTI, Inc. announced that its Non-executive Chairman, Mr. Douglas Lefort, has purchased 31,094 common shares, increasing his total holding to 1,482,715 shares, which represents approximately 1.39% of the company’s issued share capital. This transaction, conducted on the London Stock Exchange, reflects a significant investment by a key company leader, potentially signaling confidence in the company’s strategic direction and future performance.
More about AOTI, Inc.
AOTI, Inc., founded in 2006 and based in Oceanside, California, US and Galway, Ireland, specializes in providing innovative solutions for severe and chronic wound care. The company’s flagship product, the patented non-invasive Topical Wound Oxygen (TWO2®) therapy, has been shown to significantly reduce the recurrence of Diabetic Foot Ulcers and associated hospitalizations and amputations. This therapy is approved by regulatory bodies in the US, Europe, UK, Canada, China, Australia, and Saudi Arabia.
Average Trading Volume: 43,193
Technical Sentiment Signal: Strong Sell
Current Market Cap: £85.09M
For an in-depth examination of AOTI stock, go to TipRanks’ Stock Analysis page.